Baseline characteristics and outcomes of the study population
| Good outcome (n=11) | Poor outcome (n=19) | Total (n=30) | p Value | |
|---|---|---|---|---|
| Age, years (mean±SD) | 70.5±12.40 | 68.8±9.86 | 69.4 | NS |
| Sex, male (n, %) | 5 (45.5%) | 11 (57.9%) | 16 (53.3%) | NS |
| Risk factors | ||||
| Hypertension | 3 (27.2%) | 9 (47.4%) | 12 (40%) | NS |
| Atrial fibrillation | 4 (36.4%) | 13 (68.4%) | 17 (56.7%) | NS |
| Diabetes mellitus | 3 (27.2%) | 5 (26.3%) | 8 (26.7%) | NS |
| Dyslipidemia | 3 (27.2%) | 6 (31.6%) | 9 (30%) | NS |
| Smoking | 3 (27.2%) | 5 (26.3%) | 8 (26.7%) | NS |
| History of stroke or TIA | 1 (8.3%) | 1 (5.3%) | 2 (6.7%) | NS |
| Coronary artery disease | 2 (16.7%) | 2 (10.5%) | 4 (13.3%) | NS |
| Congestive heart failure | 1 (8.3%) | 1 (5.3%) | 2 (6.7%) | |
| Valvular heart disease | 0 | 1 (5.3%) | 1 (3.3%) | NS |
| Occlusion sites | ||||
| Internal carotid artery | 6 (54.5%) | 13 (68.4%) | 19 (63.3%) | NS |
| Middle cerebral artery | 2 (16.7%) | 5 (26.3%) | 7 (23.3%) | NS |
| Basilar artery | 3 (27.2%) | 1 (5.3%) | 4 (13.3%) | NS |
| Intravenous thrombolysis | 4 (36.3%) | 11 (57.9%) | 15 (50%) | NS |
| Time to procedure, min | 260±75.51 | 225±106.49 | 242.5±94.9 | NS |
| Procedure time, min | 40.0±20.99 | 45±19.74 | 41±19.85 | NS |
| Time to recanalization, min | 300±80.57 | 275±116.35 | 292.5±103.18 | NS |
| Baseline NIHSS score | 11±3.96 | 14±3.15 | 12.5±3.58 | NS |
| Discharge NIHSS score | 4.0±3.22 | 11±4.02 | 7.5±4.55 | 0.002 |
| Stroke etiology | ||||
| Large artery atherosclerosis | 4 (36.4%) | 3 (15.8%) | 7 (23.3%) | NS |
| Cardioembolic | 5 (45.5%) | 12 (63.2%) | 17 (56.7%) | NS |
| Undetermined | 2 (16.7) | 4 (21.1%) | 6 (20%) | NS |
| TICI 2b or 3 | 11 (100%) | 14 (73.7%) | 25 (83.3%) | NS |
NIHSS, National Institute of Health Stroke Scale; NS, non-significant; TIA, transient ischemic attack; TICI, Thrombolysis In Cerebral Infarction.